PBS listing makes lifesaving cancer drug affordable for sufferers

Google+ Pinterest LinkedIn Tumblr +

Sean Parnell, The Australian

Patients with leukemia and lymphoma will no longer have to pay hundreds of thousands of dollars for a drug that stops cancer cells spreading, with the Turnbull government today announcing a $460 million subsidy through the Pharmaceutical Benefits Scheme.

Two years after being approved for use in Australia by the Therapeutic Goods Administration, the drug Ibrutinib, sold under the name Imbruvica, will be listed on the PBS from December.

The drug is more effective than treatments currently available on the PBS, but until experts agreed to a government subsidy, had come at a cost of almost $190,000 on average per course of treatment…read the full article.

Share.

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply